Synthesis and Antiviral Evaluation of Carbocyclic Nucleoside Analogs of Nucleoside Reverse Transcriptase Translocation Inhibitor MK-8591 (4'-Ethynyl-2-fluoro-2'-deoxyadenosine). 2018

François-René Alexandre, and Rachid Rahali, and Houcine Rahali, and Sandra Guillon, and Thierry Convard, and Kerry Fillgrove, and Ming-Tain Lai, and Jean-Christophe Meillon, and Min Xu, and James Small, and Cyril B Dousson, and Izzat T Raheem
Idenix an MSD Company , Cap Gamma, 1682 Rue de la Valsière , 34189 Montpellier Cedex 4, France.

MK-8591 (4'-ethynyl-2-fluoro-2'-deoxyadenosine) is a novel nucleoside analog that displays a differentiated mechanism of action as a nucleoside reverse transcriptase translocation inhibitor (NRTTI) compared to approved NRTIs. Herein, we describe our recent efforts to explore the impact of structural changes to the properties of MK-8591 through the synthesis and antiviral evaluation of carbocyclic derivatives. Synthesized analogs were evaluated for their antiviral activity, and the corresponding triphosphates were synthesized and evaluated in a biochemical assay. 4'-Ethynyl-G derivative (±)-29 displayed a promising IC50 of 33 nM in a hPBMC cell-based antiviral assay, and its triphosphate (TP), (±)-29-TP, displayed an IC50 of 324 nM in a biochemical RT-polymerase assay. Improved TP anabolite delivery resulting in improved in vitro potency was achieved by preparing the corresponding phosphoramidate prodrug of single enantiomer 29b, with 6-ethoxy G derivative 34b displaying a significantly improved IC50 of 3.0 nM, paving the way for new directions for this novel class of nucleoside analogs.

UI MeSH Term Description Entries
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003839 Deoxyadenosines Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule. Adenine Deoxyribonucleosides,Adenylyldeoxyribonucleosides,Deoxyadenosine Derivatives,Deoxyribonucleosides, Adenine,Derivatives, Deoxyadenosine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse

Related Publications

François-René Alexandre, and Rachid Rahali, and Houcine Rahali, and Sandra Guillon, and Thierry Convard, and Kerry Fillgrove, and Ming-Tain Lai, and Jean-Christophe Meillon, and Min Xu, and James Small, and Cyril B Dousson, and Izzat T Raheem
July 2018, Current opinion in HIV and AIDS,
François-René Alexandre, and Rachid Rahali, and Houcine Rahali, and Sandra Guillon, and Thierry Convard, and Kerry Fillgrove, and Ming-Tain Lai, and Jean-Christophe Meillon, and Min Xu, and James Small, and Cyril B Dousson, and Izzat T Raheem
December 2009, The Journal of biological chemistry,
François-René Alexandre, and Rachid Rahali, and Houcine Rahali, and Sandra Guillon, and Thierry Convard, and Kerry Fillgrove, and Ming-Tain Lai, and Jean-Christophe Meillon, and Min Xu, and James Small, and Cyril B Dousson, and Izzat T Raheem
September 2012, Antimicrobial agents and chemotherapy,
François-René Alexandre, and Rachid Rahali, and Houcine Rahali, and Sandra Guillon, and Thierry Convard, and Kerry Fillgrove, and Ming-Tain Lai, and Jean-Christophe Meillon, and Min Xu, and James Small, and Cyril B Dousson, and Izzat T Raheem
August 2014, The Journal of biological chemistry,
François-René Alexandre, and Rachid Rahali, and Houcine Rahali, and Sandra Guillon, and Thierry Convard, and Kerry Fillgrove, and Ming-Tain Lai, and Jean-Christophe Meillon, and Min Xu, and James Small, and Cyril B Dousson, and Izzat T Raheem
August 2017, Antimicrobial agents and chemotherapy,
François-René Alexandre, and Rachid Rahali, and Houcine Rahali, and Sandra Guillon, and Thierry Convard, and Kerry Fillgrove, and Ming-Tain Lai, and Jean-Christophe Meillon, and Min Xu, and James Small, and Cyril B Dousson, and Izzat T Raheem
November 2021, Antimicrobial agents and chemotherapy,
François-René Alexandre, and Rachid Rahali, and Houcine Rahali, and Sandra Guillon, and Thierry Convard, and Kerry Fillgrove, and Ming-Tain Lai, and Jean-Christophe Meillon, and Min Xu, and James Small, and Cyril B Dousson, and Izzat T Raheem
July 2010, Bioorganic & medicinal chemistry letters,
François-René Alexandre, and Rachid Rahali, and Houcine Rahali, and Sandra Guillon, and Thierry Convard, and Kerry Fillgrove, and Ming-Tain Lai, and Jean-Christophe Meillon, and Min Xu, and James Small, and Cyril B Dousson, and Izzat T Raheem
August 2016, Proceedings of the National Academy of Sciences of the United States of America,
François-René Alexandre, and Rachid Rahali, and Houcine Rahali, and Sandra Guillon, and Thierry Convard, and Kerry Fillgrove, and Ming-Tain Lai, and Jean-Christophe Meillon, and Min Xu, and James Small, and Cyril B Dousson, and Izzat T Raheem
March 2012, Antimicrobial agents and chemotherapy,
François-René Alexandre, and Rachid Rahali, and Houcine Rahali, and Sandra Guillon, and Thierry Convard, and Kerry Fillgrove, and Ming-Tain Lai, and Jean-Christophe Meillon, and Min Xu, and James Small, and Cyril B Dousson, and Izzat T Raheem
February 2017, Organic letters,
Copied contents to your clipboard!